Osteopontin-Enhanced Hepatic Metastasis of Colorectal Cancer Cells

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Huang, Jianjin ^a   Pan, Chi ^a   Hu, Hanguang ^a   Zheng, Shu ^a   Ding, Ling ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V6 ANTIGEN; CD51 ANTIGEN; GLYCOPROTEIN; MESSENGER RNA; OSTEOPONTIN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER TISSUE; CELL ADHESION; CELL ASSAY; CELL COMMUNICATION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER METASTASIS; MUCOSA; PLASMID; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANTIGENS, CD44; CELL ADHESION; CELL COMMUNICATION; CELL LINE, TUMOR; COLON; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN ALPHAV; LIVER; LIVER NEOPLASMS; OSTEOPONTIN; RECTUM; RNA, MESSENGER;

CITRUS MACROPHYLLA; EUKARYOTA;

EID: 84868133056     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047901     Document Type: Article

References (22)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Ruers T, Bleichrodt RP, (2002) Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 38: 1023-1033.
3. Siegel RL, Jemal A, Thun MJ, Hao Y, Ward EM, (2008) Trends in the incidence of colorectal cancer in relation to county-level poverty among blacks and whites. J Natl Med Assoc 100: 1441-1444.
4. Yeatman TJ, Chambers AF, (2003) Osteopontin and colon cancer progression. Clin Exp Metastasis 20: 85-90.
5. Oldberg A, Franzen A, Heinegard D, (1986) Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci U S A 83: 8819-8823.
6. Rodrigues LR, Teixeira JA, Schmitt FL, Paulsson M, Lindmark-Mansson H, (2007) The role of osteopontin in tumor progression and metastasis in breast cancer. Cancer Epidemiol Biomarkers Prev 16: 1087-1097.
7. Hotte SJ, Winquist EW, Stitt L, Wilson SM, Chambers AF, (2002) Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma. Cancer 95: 506-512.
8. Ramankulov A, Lein M, Kristiansen G, Loening SA, Jung K, (2007) Plasma osteopontin in comparison with bone markers as indicator of bone metastasis and survival outcome in patients with prostate cancer. Prostate 67: 330-340.
9. Cui BK, Zhang CQ, Zhang Y, Yuan YF, Zhang YQ, et al. (2006) [Osteopontin as a potential biomarker of metastasis and recurrence for hepatocellular carcinoma]. Ai Zheng 25: 876-879.
10. Rangel J, Nosrati M, Torabian S, Shaikh L, Leong SP, et al. (2008) Osteopontin as a molecular prognostic marker for melanoma. Cancer 112: 144-150.
11. Hu Z, Xiao T, Lin DM, Guo SP, Zhang ZQ, et al. (2007) [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance]. Zhonghua Zhong Liu Za Zhi 29: 591-595.
12. Hayashi C, Rittling S, Hayata T, Amagasa T, Denhardt D, et al. (2007) Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration. J Cell Biochem 101: 979-986.
13. Zheng YH, Tian C, Meng Y, Qin YW, Du YH, et al. (2012) Osteopontin stimulates autophagy via integrin/CD44 and p38 MAPK signaling pathways in vascular smooth muscle cells. J Cell Physiol 227: 127-135.
14. Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, et al. (2003) Osteopontin identified as colon cancer tumor progression marker. C R Biol 326: 1041-1043.
15. Salameh A, Dhein S, (2005) Pharmacology of gap junctions. New pharmacological targets for treatment of arrhythmia, seizure and cancer? Biochim Biophys Acta 1719: 36-58.
16. Carruba G, Stefano R, Cocciadiferro L, Saladino F, Di Cristina A, et al. (2002) Intercellular communication and human prostate carcinogenesis. Ann N Y Acad Sci 963: 156-168.
17. Wai PY, Mi Z, Guo H, Sarraf-Yazdi S, Gao C, et al. (2005) Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis. Carcinogenesis 26: 741-751.
18. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, et al. (1993) An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 270: 943-947.
19. Eschrich S, Yang I, Bloom G, Kwong KY, Boulware D, et al. (2005) Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 23: 3526-3535.
20. Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, et al. (2002) Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94: 513-521.
21. Liotta LA (1992) Cancer cell invasion and metastasis. Sci Am 266: 54-59, 62-53.
22. Trosko JE, Ruch RJ, (2002) Gap junctions as targets for cancer chemoprevention and chemotherapy. Curr Drug Targets 3: 465-482.